you are in demo mode.    to view your own genetic profile, order your scan now.

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

The most recent disease risk model uses 1 variant that was not measured in your genetic scan and therefore the results presented here may not be as accurate as possible. See the table in scientific details for further information.

Recent changes:
Jan 04 2010, 12:45 PM Added two risk variants for Europeans
Oct 27 2009, 03:45 PM Added seventeen risk variants for Europeans

Type 1 Diabetes

Type 1 diabetes (T1D) (also called insulin-dependent diabetes or juvenile-onset diabetes) accounts for 5 to 10% of all diagnosed cases of diabetes.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity:  European ancestry

Gender:   

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

Male

Trait_male_female

change


T1d
According to the selected literature, the relative genetic risk calculated from your genotype for males of European ancestry is 0.40. This corresponds to a 0.2% lifetime risk of developing type 1 diabetes, which is 60% less than for males of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 16 of every 10000 males of European ancestry with your genotype variants develop this disease in their lifetime.
T1d
The average lifetime risk
On average, about 40 of every 10000 males of European ancestry develop this disease in their lifetime.
T1d

Consult with our experts


Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Type 1 Diabetes

Keep in mind


These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).